AAAAAA

   
Results: 1-9 |
Results: 9
NO-NAPROXEN VS NAPROXEN - ULCEROGENIC, ANALGESIC AND ANTIINFLAMMATORYEFFECTS
Authors: DAVIES NM ROSETH AG APPLEYARD CB MCKNIGHT W DELSOLDATO P CALIGNANO A CIRINO G WALLACE JL
Citation: Nm. Davies et al., NO-NAPROXEN VS NAPROXEN - ULCEROGENIC, ANALGESIC AND ANTIINFLAMMATORYEFFECTS, Alimentary pharmacology & therapeutics, 11(1), 1997, pp. 69-79
PROLONGED EPITHELIAL DYSFUNCTION AND TRANS-EPITHELIAL NEUTROPHIL MIGRATION FOLLOWING COLITIS IN THE RAT
Authors: ASFAHA S BELL CJ SUNDSET AT ROSETH AG WALLACE JL MACNAUGHTON WK
Citation: S. Asfaha et al., PROLONGED EPITHELIAL DYSFUNCTION AND TRANS-EPITHELIAL NEUTROPHIL MIGRATION FOLLOWING COLITIS IN THE RAT, Gastroenterology, 112(4), 1997, pp. 346-346
INFILTRATING GRANULOCYTES ARE THE KEY EFFECTORS OF INJURY AND THE PRIMARY SOURCE OF INDUCIBLE NO SYNTHASE MESSENGER-RNA IN A MODEL OF REACTIVATED COLITIS
Authors: ASFAHA S MACNAUGHTON WK MCKNIGHT W SUNDSET AT ROSETH AG WALLACE JL
Citation: S. Asfaha et al., INFILTRATING GRANULOCYTES ARE THE KEY EFFECTORS OF INJURY AND THE PRIMARY SOURCE OF INDUCIBLE NO SYNTHASE MESSENGER-RNA IN A MODEL OF REACTIVATED COLITIS, Gastroenterology, 112(4), 1997, pp. 925-925
ASSESSMENT OF DISEASE-ACTIVITY IN ULCERATIVE-COLITIS BY FECAL CALPROTECTIN, A NOVEL GRANULOCYTE MARKER PROTEIN
Authors: ROSETH AG AADLAND E JAHNSEN J RAKNERUD N
Citation: Ag. Roseth et al., ASSESSMENT OF DISEASE-ACTIVITY IN ULCERATIVE-COLITIS BY FECAL CALPROTECTIN, A NOVEL GRANULOCYTE MARKER PROTEIN, Digestion, 58(2), 1997, pp. 176-180
GRANULOCYTE MARKER PROTEIN (GMP) IS ELEVATED IN STOOLS FROM RATS WITHAZOXYMETHANE-INDUCED COLON-CANCER AND ABERRANT CRYPTS
Authors: KRISTINSSON J ROSETH AG SUNDSET A NYGAARD K AADLAND E LOBERG EM PAULSEN JE FAGERHOL MK
Citation: J. Kristinsson et al., GRANULOCYTE MARKER PROTEIN (GMP) IS ELEVATED IN STOOLS FROM RATS WITHAZOXYMETHANE-INDUCED COLON-CANCER AND ABERRANT CRYPTS, Gastroenterology, 110(4), 1996, pp. 546-546
FECAL CALPROTECTIN IS ELEVATED IN PATIENTS WITH GASTRIC-CANCER
Authors: KRISTINSSON J ROSETH AG NYGAARD K AADLAND E FAGERHOL MK SCHJONSBY H
Citation: J. Kristinsson et al., FECAL CALPROTECTIN IS ELEVATED IN PATIENTS WITH GASTRIC-CANCER, Gastroenterology, 108(4), 1995, pp. 493-493
FECAL LACTOFERRIN, A NOVEL MARKER OF COLORECTAL-CANCER IN RATS, A LONGITUDINAL IN-VIVO STUDY
Authors: ROSETH AG KRISTINSSON J NYGAARD K AADLAND E SUNDSET A FAGERHOL MK
Citation: Ag. Roseth et al., FECAL LACTOFERRIN, A NOVEL MARKER OF COLORECTAL-CANCER IN RATS, A LONGITUDINAL IN-VIVO STUDY, Gastroenterology, 108(4), 1995, pp. 530-530
FECAL CALPROTECTIN - A NOVEL TEST FOR THE DIAGNOSIS OF COLORECTAL-CANCER
Authors: ROSETH AG KRISTINSSON J FAGERHOL MK SCHJONSBY H AADLAND E NYGAARD K ROALD B
Citation: Ag. Roseth et al., FECAL CALPROTECTIN - A NOVEL TEST FOR THE DIAGNOSIS OF COLORECTAL-CANCER, Scandinavian journal of gastroenterology, 28(12), 1993, pp. 1073-1076
CALPROTECTIN - A SENSITIVE MARKER OF GASTROINTESTINAL NEOPLASIA
Authors: ROSETH AG KRISTINSSON J AADLAND E SCHJONSBY H NYGAARD K FAGERHOL MK
Citation: Ag. Roseth et al., CALPROTECTIN - A SENSITIVE MARKER OF GASTROINTESTINAL NEOPLASIA, Gastroenterology, 104(4), 1993, pp. 445-445
Risultati: 1-9 |